Skip to product information
1 of 1
Regular price £105.69 GBP
Regular price £118.00 GBP Sale price £105.69 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Redox and Cancer Part A

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research.

Kenneth D. Tew (Series edited by), Danyelle Townsend (Volume editor)

9780124201170, Elsevier Science

Hardback, published 12 August 2014

338 pages
22.9 x 15.1 x 2.4 cm, 0.75 kg

Praise for the Series:
"Excellent, highly informative, in-depth reviews... expertly written, up-to-date, and well-referenced." --JOURNAL OF MEDICINAL CHEMISTRY

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics — Volume 122 explores subjects related to redox, including: redox homeostasis in epithelial-derived cancers; reactive oxygen species in normal and tumor stem cells; and gamma-glutamyl transpeptidase and redox regulation.

1. Reactive Oxygen Species in Normal and Tumor Stem Cells 2. Emerging Regulatory Paradigms in Glutathione Metabolism 3. Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance 4. Pleiotropic Functions of Glutathione S-Transferase P 5. A Comparison of Reversible versus Irreversible Protein Glutathionylation 6. Glutathione Transferases in the Bioactivation of Azathioprine 7. Thioredoxin and Hematological Malignancies 8. Role of the Keap1-Nrf2 Pathway in Cancer

Subject Areas: Biochemistry [PSB], Oncology [MJCL]

View full details